These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8051150)

  • 41. Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.
    Varfaj F; Neuberg J; Jenkins PV; Wakabayashi H; Fay PJ
    Biochem J; 2006 Jun; 396(2):355-62. PubMed ID: 16503879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial activation of the factor VIIIa-factor IXa enzyme complex by dihexanoic phosphatidylserine at submicellar concentrations.
    Gilbert GE; Arena AA
    Biochemistry; 1997 Sep; 36(35):10768-76. PubMed ID: 9271508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of amino-terminal residues of the heavy chain of factor IXa in the binding of its cofactor, factor VIIIa.
    Hamaguchi N; Bajaj SP; Smith KJ; Stafford DW
    Blood; 1994 Sep; 84(6):1837-42. PubMed ID: 8080989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
    Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
    Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.
    Venkateswarlu D
    BMC Struct Biol; 2010 Feb; 10():7. PubMed ID: 20184747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.
    Lenting PJ; van de Loo JW; Donath MJ; van Mourik JA; Mertens K
    J Biol Chem; 1996 Jan; 271(4):1935-40. PubMed ID: 8567641
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
    Sheehan JP; Kobbervig CE; Kirkpatrick HM
    Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Glu113Ala mutation within a factor VIII Ca2+-binding site enhances cofactor interactions in factor Xase.
    Wakabayashi H; Su YC; Ahmad SS; Walsh PN; Fay PJ
    Biochemistry; 2005 Aug; 44(30):10298-304. PubMed ID: 16042406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex.
    Ngo JC; Huang M; Roth DA; Furie BC; Furie B
    Structure; 2008 Apr; 16(4):597-606. PubMed ID: 18400180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
    Misenheimer TM; Buyue Y; Sheehan JP
    Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
    Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA
    J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factor VIII structure and function.
    Fay PJ
    Int J Hematol; 2006 Feb; 83(2):103-8. PubMed ID: 16513527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
    Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
    J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
    Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
    J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The influence of sodium ion binding on factor IXa activity.
    Gopalakrishna K; Rezaie AR
    Thromb Haemost; 2006 Jun; 95(6):936-41. PubMed ID: 16732371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
    Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
    Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex.
    Jenkins PV; Freas J; Schmidt KM; Zhou Q; Fay PJ
    Blood; 2002 Jul; 100(2):501-8. PubMed ID: 12091341
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select hemophilia B mutants.
    Bajaj SP
    Thromb Haemost; 1999 Aug; 82(2):218-25. PubMed ID: 10605707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exposed hydrophobic sites in factor VIII and isolated subunits.
    Sudhakar K; Fay PJ
    J Biol Chem; 1996 Sep; 271(38):23015-21. PubMed ID: 8798489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of the A1 subunit of factor VIIIa and the serine protease domain of factor X identified by zero-length cross-linking.
    Lapan KA; Fay PJ
    Thromb Haemost; 1998 Sep; 80(3):418-22. PubMed ID: 9759621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.